PerpEquities

GenScript Biotech Corporation (GENSCRIPT) income statement

HKSE · Healthcare · Biotechnology · 6,135 employees · CEO Weihui Shao

Price
$3.54 0.0%
Market cap
$7.97B
Enterprise value
$8B Data as of 2026-11-21
Last report
Q2 '26 filed 2026-06-30
Next report
2027-03-24

GenScript Biotech Corporation (GENSCRIPT) reported revenue of $403M for Q2 '26 (-22.3% year on year), operating income of $49.4M (12.3% of revenue) and net income of -$129M. Over the last two half-years revenue was $844M.

Income statement

Income statementTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Revenue$224M$230M$261M$310M$316M$391M$448M$285M$309M$519M$441M$403M
Cost of revenue$76.7M$90.9M$117M$141M$181M$216M$214M$152M$171M$198M$208M$197M
Gross profit$148M$139M$144M$168M$136M$175M$235M$134M$139M$321M$233M$206M
Research & development$148M$175M$183M$178M$212M$207M$225M$24.9M$28.9M$31.3M$39.9M$39.3M
Sales & marketing$66.3M$58.3M$110M$86.9M$81.4M$81.4M$92.9M$43.1M$45.1M$47.5M$52M$0
General & administrative$54M$56.3M$78.2M$79.6M$103M$107M$107M$52.7M$61.6M$63.1M$65.4M$0
Operating expenses$278M$288M$516M$399M$336M$398M$428M$125M$138M$142M$156M$157M
Operating income-$120M-$152M-$227M-$177M-$261M-$223M-$193M$8.95M$331K$179M$76.2M$49.4M
Interest income$6.79M$1.14M$5.32M$1.07M$3.18M$13.5M$32.2M$101M$28.9M$711K$16.2M$7.9M
Interest expense$0$0$0$0$0$0$0$0$8.03M$0$8.11M$6.38M
Total non-operating income-$4.01M$2.1M-$140M-$52.5M$58.8M-$22.1M$86.9M-$137M-$43.2M-$179M-$547M-$169M
Income before tax-$124M-$150M-$367M-$230M-$202M-$245M-$106M-$128M-$42.9M-$119K-$470M-$119M
Income tax-$2.94M$5.93M-$4.96M$3.81M-$7.53M$1.1M$3.04M$9.81M$6.84M$24.4M$37.4M$9.9M
Net income-$91.9M-$91.1M-$268M-$136M-$91.3M-$93.6M-$1.9M-$175M$3.14B-$25.5M-$507M-$129M
EPS (basic)-$0.05-$0.05-$0.13-$0.06-$0.04-$0.04-$0.00-$0.05$0.01-$0.01-$0.24-$0.06
EPS (diluted)-$0.05-$0.05-$0.13-$0.06-$0.04-$0.04-$0.00-$0.05$0.01-$0.02-$0.23-$0.06
Shares (basic, weighted)1.92B1.98B2.08B2.09B2.1B2.11B1.99B2.12B2.18B1.18B2.18B2.19B
Shares (diluted, weighted)1.92B1.98B2.09B2.09B2.1B2.11B2.11B2.12B2.18B2.16B2.23B2.19B
Depreciation & amortization$18.8M$23M$24.7M$30M$34.3M$35.5M$38.4M$29.6M$21.3M$35M$39.2M$40.4M
EBITDA-$101M-$129M-$202M-$147M-$226M-$187M-$155M$38.5M$21.6M$214M$115M$89.9M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Revenue, operating income and growth

quarterly

Margins

quarterly

Costs as % of revenue

quarterly

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-21